Three Times of the Clock Drawing Test Rated with BaJa Scoring in Patients with Early Alzheimer‘s Disease

Česká verzia

Authors: A. Bartoš ^1,2,3; M. Janoušek ^1,3; R. Petroušová ¹; M. Hohinová ³
Authors place of work: Neurologická klinika 3. LF UK a FN Královské Vinohrady, Praha ¹; Národní ústav duševního zdraví, Klecany ²; AD Centrum, Praha ³
Published in the journal: Cesk Slov Neurol N 2016; 79/112(4): 406-412
Category: Original Paper

Summary

Aim:
The Clock Drawing Test (CDT) is a popular screening test to detect of dementia. The aim of the present research was to determine the role of the test in diagnosing early stages of Alzheimer‘s disease (AD).

Patients and methods:
The Mini-Mental State Examination (MMSE) and the CDT with three times 11:10, 23:20 and 5:40 were examined in 77 cognitively normal seniors (NOS) and in 77 patients diagnosed with early AD according to NIA-AA criteria. All CDTs were scored according to the instructions in the Addenbrooke´s and Montreal cognitive tests (ACE, MoCA), Shulman´s system and by our newly developed BaJa system with five dichotomous questions and 0–5 scale.

Results:
MMSE and CDT scores with any of the three times (11:10, 23:20, 5:40) assessed by any system were significantly lower for the early AD patients than for the NOS group (p < 0.01). The 23:20 was significantly more difficult than 11:10 for all participants (p = 0.003). A comparison of patients and NOS for three times of the CDT showed a cut-off score for BaJa ≤ 4 points, sensitivity 54–65%, specificity of 59–75% and the area under the receiver operating curve (AUC) around 0.7. The MMSE cut-off score ≤ 27 points was associated with higher sensitivity of 86%, specificity 96% and AUC 0.96. There were no differences between the four CDT scoring systems with respect to AUCs.

Conclusion:
Although the CDT with 23:20 is more difficult than the other times, the CDT in general is not useful for early detection of AD due to its low sensitivity and specificity, regardless of what time or scoring system is used.

Key words:
Clock Drawing Test – Mini-Mental State Examination – mild cognitive impairment –Alzheimer‘s disease – dementia screening – test – diagnosis

The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study.

The Editorial Board declares that the manuscript met the ICMJE “uniform requirements” for biomedical papers.

Zdroje

1. Bartoš A, Raisová M. Testy a dotazníky pro vyšetřování kognitivních funkcí, nálady a soběstačnosti. Praha: Mladá fronta 2015.

2. Preiss M. Test hodin. Neuropsychologická screeningová zkouška. Čes a Slov Psychiat 1998;94(6):330– 5.

3. Sunderland T, Hill JL, Mellow AM, et al. Clock drawing in Alzheimer’s disease: a novel measure of dementia severity. J Am Geriatr Soc 1989;37(8):725– 9.

4. Ismail Z, Rajji TK, Shulman KI. Brief cognitive screening instruments: an update. Int J Geriatr Psychiatry 2010;25(2):111– 20. doi: 10.1002/ gps.2306.

5. Ressner P, Ressnerová E. Test hodin, přehledná informace a zhodnocení škál dle Shulmana, Sunderlanda a Hendriksena. Neurol pro Praxi 2002;6:316– 22.

6. Shulman KI. Clock-drawing: is it the ideal cognitive screening test? Int J Geriatr Psychiatry 2000;15(6):548– 61.

7. Shulman KI, Gold DP, Cohen CA, et al. Clock-drawing and dementia in the community: a longitudinal study. Int J Geriatr Psychiatry 1993;8:487– 96.

8. Babins L, Slater ME, Whitehead V, et al. Can an 18--point clock-drawing scoring system predict dementia in elderly individuals with mild cognitive impairment? J Clin Exp Neuropsychol 2008;30(2):173– 86. doi: 10.1080/ 13803390701336411.

9. Cohen MJ, Ricci CA, Kibby MY, et al. Developmental progression of clock face drawing in children. Child Neuropsychol 2000;6(1):64– 76.

10. Mainland BJ, Amodeo S, Shulman KI. Multiple clock drawing scoring systems: simpler is better. Int J Geriatr Psychiatry 2014;29(2):127– 36. doi: 10.1002/ gps.3992.

11. Pinto E, Peters R. Literature review of Clock drawing test as a tool for cognitive screening. Dement Geriatr Cogn Disord 2009;27:201– 13. doi: 10.1159/ 000203344.

12. Lonie JA, Tierney KM, Ebmeier KP. Screening for mild cognitive impairment: a systematic review. Int J Geriatr Psychiatry 2009;24(9):902– 15. doi: 10.1002/ gps.2208.

13. Ehreke L, Luppa M, König HH, et al. Is the Clock Drawing Test a screening tool for diagnosis of mild cognitive impairment? A systematic rewiev. Int Psychogeriatr 2010;22(1):56– 63. doi: 10.1017/ S1041610209990676.

14. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53(4):695– 9.

15. Bartoš A, Orlíková H, Raisová M, et al. Česká tréninková verze Montrealského kognitivního testu (MoCA-CZ1) k časné detekci Alzheimerovy nemoci. Cesk Slov Neurol N 2014;77/ 110(5):587– 95.

16. Orlíková H, Bartoš A, Raisová M, et al. Montrealský kognitivní test (MoCA) k záchytu mírné kognitivní poruchy a časné Alzheimerovy nemoci. Psychiatrie 2014;18(1):18– 25.

17. Mioshi E, Dawson K, Mitchell J, et al. The Addenbrooke‘s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 2006;21(11):1078– 85.

18. García-Caballero A, Recimil MJ, García-Lado I, et al. ACE clock scoring: a comparison with eight standard correction methods in a population of low educational level. J Geriatr Psychiatry Neurol 2006;19(4):216– 9.

19. Bartoš A, Raisová M, Kopeček M. Novelizace české verze Addenbrookského kognitivního testu (ACE-CZ). Cesk Slov Neurol N 2011;74/ 107(6):681– 4.

20. Bartoš, A, Raisová M, Kopeček M. Důvody a průběh novelizace české verze Addenbrookského kognitivního testu (ACE-CZ). Cesk Slov Neurol N 2011;74/ 107(6):1– 5.

21. Hummelová-Fanfrdlová Z, Rektorová I, Sheardová K, et al. Česká adaptace Addenbrookského kognitivního testu (Addenbrooke’s Cognitive Examination). Cesk Psychol 2009;4:376– 88.

22. Vyhnálek M, Bartoš A, Dostál V, et al. Diagnostikujeme a léčíme demence správně a včas? Výsledky průzkumu ve světle nových doporučení. Psychiatr Prax 2012;13(1):19– 24.

23. Sheardová K, Hort J, Rektorová I, et al. Dementia diagnosis and treatment in Czech neurological and psychiatric practices. Cesk Slov Neurol N 2012;75/108(2):208– 11.

24. Price CC, Cunningham H, Coronado N, et al. Clock drawing in the Montreal cognitive assessment: recommendations for dementia assessent. Dement Geriatr Cogn Disord 2011;31:179–87.

25. Powlishta KK, Von Dras DD, Stanford A, et al. The clock drawing test is a poor screen for very mild dementia. Neurology 2002;59(6):898– 903.

26. Lee H, Swanwick GR, Coen RF, et al. Use of the clock drawing task in the diagnosis of mild and very mild Alzheimer’s disease. Int Psychogeriatr 1996;8(3):469–76.

27. Ehreke L, Luck T, Luppa M, et al. Clock drawing test – screening utility for mild cognitive impairment according to different scoring systems: results of the Leipzig Longitudinal Study of the Aged (LEILA 75+). Int Psychogeriatr 2011;23(10):1592– 601. doi: 10.1017/ S104161021100144X.

28. Nishiwaki Y, Breeze E, Smeeth L, et al. Validity of the Clock-Drawing Test as a screening tool for cognitive impairment in the elderly. Am J Epidemiol 2004;160(8):797– 807.

29. Rubinova E, Nikolai T, Markova H, et al. Clock Drawing Test and the diagnosis of amnestic mild cognitive impairment: can more detailed scoring systems do the work? J Clin Exp Neuropsychol 2014;36(10):1076– 83. doi: 10.1080/ 13803395.2014.977233.

30. Yamamoto S, Mogi N, Umegaki H, et al. The clock drawing test as a valid screening method for mild cognitive impairment. Dement Geriatr Cogn Disord 2004;18(2):172– 9.

31. Patocskai AT, Pakaski M, Vincze G, et al. Is there any difference between the findings of Clock Drawing Tests if the clocks show different times? J Alzheimers Dis 2014;39(4):749– 57. doi: 10.3233/ JAD-131313.

32. Folstein MF, Folstein SE, McHugh PR. „Mini-mental state.“ A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12(3):189– 98.

33. Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011;7(3):270– 9. doi: 10.1016/ j.jalz.2011.03.008.

34. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011;7(3):263– 9. doi: 10.1016/ j.jalz.2011.03.005.

35. Bartoš A. Kdy vlastně začíná Alzheimerova nemoc – nová kritéria mírné kognitivní poruchy a Alzheimerovy nemoci. Cesk Slov Neurol N 2012;75/ 108(1):108– 9.

36. Bartoš A, Čechová L, Švarcová J, et al. Likvorový triplet (tau proteiny a beta-amyloid) v diagnostice Alzheimerovy-Fisherovy nemoci. Cesk Slov Neurol N 2012;75/ 108(5):587– 94.

37. Bartoš A, Píchová R, Trojanová H, et al. SPECT mozku v diagnostice Alzheimerovy nemoci. Psychiatrie 2008;12(Suppl 3):8– 11.

38. Bartoš A, Zach P, Diblíková F, et al. Vizuální kategorizace mediotemporální atrofie na MR mozku u Alzheimerovy nemoci. Psychiatrie 2007;11(Suppl 3):49– 52.

39. Dušek L, Pavlík T, Koptíková J. Analýza dat v neurologii VI. Přesnost, spolehlivost a reprodukovatelnost měření u diskrétních dat. Cesk Slov Neurol N 2007;70/ 103(6):719– 21.

40. Mittal C, Gorthi CS, Rohatgi MG. Early cognitive impairment: role of clock drawing test. MJAFI 2010;66:20– 8.

41. Scanlan JM, Brush M, Quijano C, et al. Comparing clock tests for dementia screening: naive judgements vs. formal systéme – what is optimal? Int J Geriatr Psychiatry 2002;17(1):14– 21.

42. Schramm U, Berger G, Müller R, et al. Psychometric properties of Clock drawing test and MMSE or Short Performance Test (SKT) in dementia screening in a memory clinic population. Int J Geriatr Psychiatry 2002;17(3):254– 60.